Karl Burgoyne

Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs

Jambur Ananth, Sharat Parameswaran, Sarath Gunatilake et al. · The Journal of Clinical Psychiatry · 2004 · 274 citations

Medicine, Pharmacology, Psychiatry +12

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study

Andrew F. Leuchter, Ian A. Cook, Lauren B. Marangell et al. · Psychiatry Research · 2009 · 177 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression

Andrew F. Leuchter, Ian A. Cook, David Feifel et al. · Brain stimulation · 2015 · 138 citations · Full text

Life Sciences, Neuroscience, Psychiatry +10

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder

Andrew F. Leuchter, Ian A. Cook, William S. Gilmer et al. · Psychiatry Research · 2009 · 120 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Atypical Antipsychotic Drug Use and Diabetes

Jambur Ananth, Ravi Venkatesh, Karl Burgoyne et al. · Psychotherapy and Psychosomatics · 2002 · 58 citations

Medicine, Pharmacology, Psychiatry +13